The genomic landscape of oesophagogastric junctional adenocarcinoma

Journal of Pathology

Volumn 231, Issue 3, 2013, Pages 301-310

  Chong, Irene Y ^a,b   Cunningham, David ^b   Barber, Louise J ^a   Campbell, James ^a   Chen, Lina ^a   Kozarewa, Iwanka ^a   Fenwick, Kerry ^a   Assiotis, Ioannis ^a   Guettler, Sebastian ^a   Garcia Murillas, Isaac ^a   Awan, Saima ^a   Lambros, Maryou ^a   Starling, Naureen ^b   Wotherspoon, Andrew ^b   Stamp, Gordon ^b   Gonzalez De Castro, David ^b   Benson, Martin ^b   Chau, Ian ^b   Hulkki, Sanna ^b   Nohadani, Mahrokh ^b   Eltahir, Zakaria ^b   Lemnrau, Alina ^a   Orr, Nicholas ^a   Rao, Sheela ^b   Lord, Christopher J ^a   Ashworth, Alan ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

actionable mutations; drug targets; exome sequencing; oesophagogastric junctional adenocarcinoma; subclonal mutations

Indexed keywords

PROTEIN P53;

ARID1A GENE; ARTICLE; CONTROLLED STUDY; CR2 GENE; DNA SEQUENCE; ESOPHAGOGASTRIC JUNCTIONAL ADENOCARCINOMA; ESRRB GENE; FGFR4 GENE; GASTROINTESTINAL CARCINOMA; GENE; GENE DOSAGE; GENE IDENTIFICATION; GENOMICS; GERM LINE; HGF GENE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; SOMATIC MUTATION; STOMACH CANCER; SYNE1 GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; DNA REPAIR ENZYMES; DNA, NEOPLASM; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; EXOME; FEMALE; GENOME, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84885415139     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4247     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Kamangar F, Dores GM, Anderson WF,. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.
3. Kubo A, Corley DA,. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 872-878.
4. Okines AF, Cunningham D,. Multimodality treatment for localized gastro-oesophageal cancer. Ann Oncol 2010; 21 (Suppl 7): vii286-293.
5. Enzinger PC, Mayer RJ,. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252.
6. Aklilu M, Ilson DH,. Targeted agents and esophageal cancer-the next step? Semin Radiat Oncol 2007; 17: 62-69.
7. Ajani JA, Barthel JS, Bentrem DJ, et al., Esophageal and esophagogastric junction cancers. J Natl Compr Cancer Netw 2011; 9: 830-887.
8. Ruschoff J., Adenocarcinoma of the GEJ: gastric or oesophageal cancer? Recent Results Cancer Res 2012; 196: 107-113.
9. Isinger-Ekstrand A, Johansson J, Ohlsson M, et al., Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array-comparative genomic hybridization. Cancer Genet Cytogenet 2010; 200: 120-126.
10. Goh XY, Rees JR, Paterson AL, et al., Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma. Gut 2011; 60: 1317-1326.
11. Dulak AM, Schumacher SE, van Lieshout J, et al., Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res 2012; 72: 4383-4393.
12. Li X, Galipeau PC, Sanchez CA, et al., Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila) 2008; 1: 413-423.
13. Li H, Durbin R,. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
14. McKenna A, Hanna M, Banks E, et al., The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297-1303.
15. Cibulskis K, Lawrence MS, Carter SL, et al., Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnol 2013; 31: 213-219.
16. Van Loo P, Nordgard SH, Lingjaerde OC, et al., Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 2010; 107: 16910-16915.
17. Buhard O, Cattaneo F, Wong YF, et al., Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J Clin Oncol 2006; 24: 241-251.
18. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268.
19. Hewish M, Lord CJ, Martin SA, et al., Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nature Rev Clin Oncol 2010; 7: 197-208.
20. Siewert JR, Stein HJ,. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-1459.
21. Dulak AM, Stojanov P, Peng S, et al., Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nature Genet 2013; 45: 478-486.
22. Holbrook JD, Parker JS, Gallagher KT, et al., Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine. J Transl Med 2011; 9: 119.
23. Zang ZJ, Cutcutache I, Poon SL, et al., Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nature Genet 2012; 44: 570-574.
24. Wang K, Kan J, Yuen ST, et al., Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nature Genet 2011; 43: 1219-1223.
25. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-337.
26. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-1068.
27. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615.
28. Konopka B, Janiec-Jankowska A, Kwiatkowska E, et al., PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors. Hum Pathol 2011; 42: 1710-1719.
29. Bachman KE, Argani P, Samuels Y, et al., The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 2004; 3: 772-775.
30. Qian CN, Furge KA, Knol J, et al., Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models. Cancer Res 2009; 69: 8256-8264.
31. Zang ZJ, Ong CK, Cutcutache I, et al., Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing. Cancer Res 2011; 71: 29-39.
32. Agrawal N, Jiao Y, Bettegowda C, et al., Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2012; 2: 899-905.
33. Nagarajan N, Bertrand D, Hillmer AM, et al., Whole-genome reconstruction and mutational signatures in gastric cancer. Genome Biol 2012; 13: R115.
34. Sophic Alliance. The Integrated Druggable Genome Database. Rockville, MD, USA: Sophic Systems Alliance Inc; 2013. http://www.sophicalliance.com/
35. Guichard C, Amaddeo G, Imbeaud S, et al., Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genet 2012; 44: 694-698.
36. Govindan R, Ding L, Griffith M, et al., Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012; 150: 1121-1134.
37. Landau DA, Carter SL, Stojanov P, et al., Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013; 152: 714-726.